Nymox Pharmaceutical Corp (NASDAQ:NYMX)

0.6199
Delayed Data
As of 3:59pm ET
 -0.0101 / -1.60%
Today’s Change
0.33
Today|||52-Week Range
5.83
+54.97%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close0.63
Today’s open0.65
Day’s range0.57 - 0.69
Volume591,461
Average volume (3 months)399,657
Market cap$22.6M
Dividend yield--
Data as of 3:59pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KBIOKaloBios Pharmaceuti...+0.06+7.86%
PRPHProPhase Labs Inc-0.06-4.54%
RGDXResponse Genetics In...+0.02+3.64%
BGMDBG Medicine Inc-0.02-3.32%
Data as of 4:00pm ET, 03/04/2015

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account